Lausanne, Switzerland

Emanuele Gabellieri

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Emanuele Gabellieri: Innovator in Tau Aggregate Research

Introduction

Emanuele Gabellieri is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of medical research, particularly in the treatment of disorders associated with Tau protein aggregates. With a total of eight patents to his name, Gabellieri's work is paving the way for advancements in therapies for neurodegenerative diseases.

Latest Patents

Gabellieri's latest patents focus on novel compounds aimed at treating or alleviating disorders linked to Tau aggregates. These compounds are particularly relevant for conditions such as Alzheimer's disease, which is characterized by the presence of Neurofibrillary Tangles (NFTs). His innovative approach addresses the need for effective treatments for these debilitating disorders.

Career Highlights

Throughout his career, Emanuele Gabellieri has worked with prominent companies in the biotechnology sector, including Ac Immune SA and Life Molecular Imaging SA. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Gabellieri has collaborated with notable professionals, including Sreenivasachary Nampally and Heiko Kroth. These partnerships have enhanced his research efforts and expanded the impact of his inventions.

Conclusion

Emanuele Gabellieri's work in the field of Tau aggregate research exemplifies the importance of innovation in addressing complex medical challenges. His contributions are vital for the development of new therapies for neurodegenerative diseases, and his patents reflect a commitment to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…